ArticleBlood cancer journal2021

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.

Andrew H Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.